This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Michael Schur - Innovator in Medicinal Chemistry
Introduction
Michael Schur is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on polymorphic forms of chemical compounds. His expertise and dedication have led to advancements that may benefit the pharmaceutical industry.
Latest Patents
Michael Schur holds a patent for "Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide." This invention relates to polymorphic forms and solvates of the compound, processes for their preparation, and their use in the development of medicaments. He has 1 patent to his name, showcasing his innovative contributions to the field.
Career Highlights
Michael Schur is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to work on groundbreaking research in medicinal chemistry. His role at the company allows him to collaborate with other experts in the field and contribute to the development of new therapeutic solutions.
Collaborations
Throughout his career, Michael has worked alongside talented colleagues such as Norbert Nagel and Harald Berchtold. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective projects.
Conclusion
Michael Schur is a prominent figure in the field of medicinal chemistry, with a focus on innovative solutions for drug development. His work and collaborations continue to pave the way for future advancements in the pharmaceutical industry.